Result as attached

Profit growth above 25%EBITDA margin expansionExceptional itemDebt to equity above the thresholdResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.8%Reaction day

₹139.00

prior close

₹139.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-3.6% vs market

Healthcare Service Provider peers, median of 24sector-1.2%-1.6% vs sector

On the reaction day the stock moved 3.6 pts less than Nifty Microcap 250 and 1.6 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.2

10m

+0.7

15m

+0.7

30m

+0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.8+0.7-3.6-1.2-1.6

Next day

-3.8+0.7-4.5+1.3-5.0

-8.6+0.0-8.7+1.2-9.8

-13.2-1.1-12.1-1.3-11.9

-12.2+0.0-12.2-0.8-11.4

-12.2+0.3-12.5-0.8-11.4

-11.5+1.1-12.6-0.6-10.9

15d

-10.1+4.9-14.9+1.6-11.7

-15.1+5.3-20.4-0.1-15.0

-18.0+6.9-24.9-4.1-13.9

+8.5+11.9-3.4+0.8+7.6

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Choksi Laboratories reported revenue from operations of ₹4,600.59 lakhs for FY2026, up 10.1% from ₹4,178.23 lakhs in FY2025. Net profit after tax grew 28.9% to ₹196.43 lakhs from ₹152.33 lakhs. EBITDA from operations was ₹244.16 lakhs vs ₹215.33 lakhs, with EBITDA margin expanding marginally from 5.14% to 5.28%. The company sold an office flat during Q4 generating an exceptional gain of ₹75.30 lakhs. The statutory auditor issued an unqualified opinion with no modifications. Long-term borrowings increased significantly to ₹1,780.99 lakhs from ₹1,523.36 lakhs. Operating cash flow remained positive at ₹786.48 lakhs though lower than the previous year's ₹1,177.80 lakhs.

Likely market impact

The company delivered healthy profit growth of nearly 29% with stable margins, but the significant increase in debt and lower operating cash flow are concerns. The one-time exceptional gain from property sale boosted reported profits. Shareholders should note the auditor raised no concerns.